Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tschritter, O.
Right arrow Articles by Fritsche, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tschritter, O.
Right arrow Articles by Fritsche, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2854-2860, 2002
© 2002 by the American Diabetes Association, Inc.

The Prevalent Glu23Lys Polymorphism in the Potassium Inward Rectifier 6.2 (KIR6.2) Gene Is Associated With Impaired Glucagon Suppression in Response to Hyperglycemia

Otto Tschritter, Michael Stumvoll, Fausto Machicao, Martin Holzwarth, Melanie Weisser, Elke Maerker, Anna Teigeler, Hans Häring, and Andreas Fritsche

From the Department of Endocrinology, Metabolism and Pathobiochemistry, Medizinische Klinik, Eberhard-Karls-Universität, Tübingen, Germany

Genetic factors play an important role in the pathogenesis of type 2 diabetes. The relevance to type 2 diabetes of the common polymorphism Glu23Lys in the potassium inward rectifier 6.2 (KIR6.2) gene is still controversial. The aim of this study was to assess whether this polymorphism influences ß-cell function, {alpha}-cell function, or insulin action. We therefore studied 298 nondiabetic subjects using an oral glucose tolerance test (OGTT) and 75 nondiabetic subjects using a hyperglycemic clamp (10 mmol/l) with additional glucagon-like peptide (GLP)-1 and arginine stimulation. The prevalence of the Lys allele was ~37%, and the Lys allele was associated with higher incremental plasma glucose during the OGTT (P = 0.03, ANOVA). Neither first- nor second-phase glucose-stimulated C-peptide secretion was affected by the presence of the polymorphism; nor were maximal glucose-, GLP-1-, or arginine-induced C-peptide secretion rates; nor was insulin sensitivity (all P > 0.7). However, the relative decrease in plasma glucagon concentrations during the 10 min after the glucose challenge was reduced in carriers of the Lys allele (10 ± 3% decrease from baseline in Lys/Lys, 18 ± 2% in Glu/Lys, and 20 ± 2% in Glu/Glu; P = 0.01, ANOVA). In conclusion, our findings suggest that the common Glu23Lys polymorphism in KIR6.2 is not necessarily associated with ß-cell dysfunction or insulin resistance but with diminished suppression of glucagon secretion in response to hyperglycemia. Our findings thus confirm its functional relevance for glucose metabolism in humans.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
L. B Nielsen, K. B Ploug, P. Swift, C. Orskov, I. Jansen-Olesen, F. Chiarelli, J. J Holst, P. Hougaard, S. Porksen, R. Holl, et al.
Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes
Eur. J. Endocrinol., June 1, 2007; 156(6): 663 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Sesti, E. Laratta, M. Cardellini, F. Andreozzi, S. Del Guerra, C. Irace, A. Gnasso, M. Grupillo, R. Lauro, M. L. Hribal, et al.
The E23K Variant of KCNJ11 Encoding the Pancreatic {beta}-Cell Adenosine 5'-Triphosphate-Sensitive Potassium Channel Subunit Kir6.2 Is Associated with an Increased Risk of Secondary Failure to Sulfonylurea in Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2334 - 2339.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Staiger, N. Stefan, H. Staiger, M. D. Brendel, D. Brandhorst, R. G. Bretzel, F. Machicao, M. Kellerer, M. Stumvoll, A. Fritsche, et al.
Adiponectin Is Functionally Active in Human Islets but Does Not Affect Insulin Secretory Function or {beta}-Cell Lipoapoptosis
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6707 - 6713.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. C. Koster, M. A. Permutt, and C. G. Nichols
Diabetes and Insulin Secretion: The ATP-Sensitive K+ Channel (KATP) Connection
Diabetes, November 1, 2005; 54(11): 3065 - 3072.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Dhindsa, D. Tripathy, N. Sanalkumar, S. Ravishankar, H. Ghanim, A. Aljada, and P. Dandona
Free Fatty Acid-Induced Insulin Resistance in the Obese Is Not Prevented by Rosiglitazone Treatment
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5058 - 5063.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. T. Hattersley and F. M. Ashcroft
Activating Mutations in Kir6.2 and Neonatal Diabetes: New Clinical Syndromes, New Scientific Insights, and New Therapy
Diabetes, September 1, 2005; 54(9): 2503 - 2513.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C. Ezenwaka, R. Kalloo, M. Uhlig, R. Schwenk, and J. Eckel
The E23K variant in the Kir6.2 subunit of the ATP-sensitive K+ channel does not augment impaired glucose tolerance in Caribbean subjects with a family history of type 2 diabetes
J. Endocrinol., June 1, 2005; 185(3): 439 - 444.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. K. Hansen, E.-M. D. Nielsen, J. Ek, G. Andersen, C. Glumer, B. Carstensen, P. Mouritzen, T. Drivsholm, K. Borch-Johnsen, T. Jorgensen, et al.
Analysis of Separate and Combined Effects of Common Variation in KCNJ11 and PPARG on Risk of Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3629 - 3637.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
F. Ashcroft and P. Rorsman
Type 2 diabetes mellitus: not quite exciting enough?
Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R21 - R31.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. D. Carr, C. L. Brand, T. B. Bodvarsdottir, J. B. Hansen, and J. Sturis
NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat
Diabetes, October 1, 2003; 52(10): 2513 - 2518.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. J. Riedel, P. Boora, D. Steckley, G. de Vries, and P. E. Light
Kir6.2 Polymorphisms Sensitize {beta}-Cell ATP-Sensitive Potassium Channels to Activation by Acyl CoAs: A Possible Cellular Mechanism for Increased Susceptibility to Type 2 Diabetes?
Diabetes, October 1, 2003; 52(10): 2630 - 2635.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E.-M. D. Nielsen, L. Hansen, B. Carstensen, S. M. Echwald, T. Drivsholm, C. Glumer, B. Thorsteinsson, K. Borch-Johnsen, T. Hansen, and O. Pedersen
The E23K Variant of Kir6.2 Associates With Impaired Post-OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes
Diabetes, February 1, 2003; 52(2): 573 - 577.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.